within Pharmacolibrary.Drugs.ATC.V;

model V09AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 740 / 1000000,
    adminCount     = 1,
    Vd             = 0.042,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Technetium (99mTc) bicisate is a radiopharmaceutical agent used as a diagnostic imaging agent in single-photon emission computed tomography (SPECT) for brain perfusion imaging, especially for identifying areas of altered perfusion indicative of stroke, epilepsy, or other neurological disorders. It is approved and in use as of today for such imaging procedures.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are based on typical adult healthy volunteers with brain SPECT imaging, as reported in primary literature and drug labeling.</p><h4>References</h4><ol><li><p>Knudsen, GM, et al., &amp; Paulson, OB (1994). Brain extraction and distribution of 99mTc-bicisate in humans and in rats. <i>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</i> 14 Suppl 1 S12–S18. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8263066/&quot;>https://pubmed.ncbi.nlm.nih.gov/8263066</a></p></li><li><p>Kikuchi, T, et al., &amp; Zhang, MR (2014). OAT3-mediated extrusion of the 99mTc-ECD metabolite in the mouse brain. <i>Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</i> 34(4) 585–588. DOI:<a href=&quot;https://doi.org/10.1038/jcbfm.2014.20&quot;>10.1038/jcbfm.2014.20</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24496177/&quot;>https://pubmed.ncbi.nlm.nih.gov/24496177</a></p></li><li><p>Inoue, K, et al., &amp; Fukuda, H (2003). Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. <i>European journal of nuclear medicine and molecular imaging</i> 30(11) 1489–1497. DOI:<a href=&quot;https://doi.org/10.1007/s00259-003-1234-x&quot;>10.1007/s00259-003-1234-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14579088/&quot;>https://pubmed.ncbi.nlm.nih.gov/14579088</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09AA02;
